WO2013127764A1 - Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides - Google Patents

Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides Download PDF

Info

Publication number
WO2013127764A1
WO2013127764A1 PCT/EP2013/053773 EP2013053773W WO2013127764A1 WO 2013127764 A1 WO2013127764 A1 WO 2013127764A1 EP 2013053773 W EP2013053773 W EP 2013053773W WO 2013127764 A1 WO2013127764 A1 WO 2013127764A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
methyl
preparation
phenyl
Prior art date
Application number
PCT/EP2013/053773
Other languages
French (fr)
Inventor
Daniel Stierli
Harald Walter
Michael Rommel
Reinhard Georg Hanreich
Martin Zeller
Thomas Vettiger
Tomas Smejkal
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU2013225123A priority Critical patent/AU2013225123B2/en
Priority to CN201380011368.1A priority patent/CN104144914B/en
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Priority to JP2014559177A priority patent/JP6078563B2/en
Priority to MX2014009948A priority patent/MX347564B/en
Priority to DK13705816.0T priority patent/DK2819997T3/en
Priority to KR1020147024947A priority patent/KR102031809B1/en
Priority to BR112014020556A priority patent/BR112014020556B1/en
Priority to CA2863467A priority patent/CA2863467C/en
Priority to PL13705816T priority patent/PL2819997T3/en
Priority to ES13705816.0T priority patent/ES2558586T3/en
Priority to EP13705816.0A priority patent/EP2819997B1/en
Priority to US14/374,547 priority patent/US9051272B2/en
Publication of WO2013127764A1 publication Critical patent/WO2013127764A1/en
Priority to IL233937A priority patent/IL233937A/en
Priority to ZA2014/05823A priority patent/ZA201405823B/en
Priority to HRP20160001TT priority patent/HRP20160001T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a process for the preparation of a compound of formula (I), wherein R1, R2 and R3 are as defined in claim 1, which process comprises a) adding a compound of formula (II), in the presence of an inert organic solvent to a mixture comprising an organic nitrite of formula (III) (R4-O-N=O (III)), wherein R4 is C1-C8alkyl, a compound of formula (IV), and an inert organic solvent; b) reacting the resulting compound of formula (V), with H2N-O-CH3 to the compound of formula (VII), c) reducing the compound of formula (VII) to the compound of formula (VIII), d) and reacting the compound of formula VIII with a compound of formula (IX), in which R* is halogen, hydroxy or C1-6 alkoxy, to the compound of formula (I).

Description

PROCESS FOR THE PREPARATION OF PHENYL SUBSTITUTED
3 - DIFLUOROMETHYL - 1 -METHYL - 1H - PYRAZOLE - 4 - CARBOXYLIC ACID
N-METHOXY- [1 -METHYL- 2 - PHENYLETHYL] AMIDES
The present invention relates to a process for the preparation of carboxamides, in particular to the preparation of phenyl-substituted 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-phenyl-ethyl]-amides.
Phenyl-substituted 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 - methyl-2-phenyl-ethyl]-amides and their microbiocidal properties are described for example inWO 2010/063700. It is known from WO 2010/063700 to prepare phenyl-substituted 3-difluoromethyl-1 -methyl- 1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-phenyl-ethyl]-amides (la) according to reaction scheme 1 starting from commercially available 2,4,6-trisubstituted benzoic acid of formula IVa. This starting material is very expensive, in particular if R siginfies chloro, and the known process is therefore less suitable for large-scale production of 3-difluoromethyl-1 - methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-phenyl-ethyl]-amides. A further disadvantage of this prior art process is the significant number of reaction steps which makes this process uneconomical.
The synthesis of the compound of formula lla, which can be reacted with the corresponding pyrazole derivative to 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 - methyl-2-phenyl-ethyl]-amide derivatives (la), is described in scheme 1 .
The disclosed reaction steps are as follows:
a) (Va), (Via), (Vila), (Villa) and (IXa);
b) (Va), (Via), (Vila), (Villa), (Xa) and (IXa);
c) (Va), (Xla), (Xlla), (Xa) and (IXa) or
d) (Va), (Xla), (Xlla), (Villa) and (IXa). Reaction scheme 1 : prior art process (R is an organic substituent):
Figure imgf000004_0001
The aim of the present invention is therefore to provide a novel process for the production of
phenyl-substituted 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 - methyl-2-phenyl-ethyl]-amides that avoids the disadvantages of the known process and makes it possible to prepare said compounds in high yields and good quality in an economically advantageous way with less reaction steps.
Thus, according to the present invention, there is provided a process for the preparation of the compound of formula I
Figure imgf000005_0001
wherein
Ri is hydrogen, halogen or d-C6alkyl;
R2 is hydrogen, halogen, CrC6alkyl, C2-C6alkenyl, C3-C6alkinyl, C3-C6cycloalkyl-C3-C6alkinyl, halophenoxy, halophenyl-C3-C6alkinyl,
Figure imgf000005_0002
CrC6haloalkyl, CrC6haloalkoxy, C2-C6haloalkenyl or C2-C6haloalkenyloxy; and
R3 is hydrogen, halogen or CrC6alkyl;
which process comprises
a) adding a compound of formula
Figure imgf000005_0003
wherein R-i, R2 and R3 have the meanings as described under formula I, in the presence of an inert organic solvent to a mixture comprising an organic nitrite of formula III
R4-0-N=0 (III), wherein R4 is CrC8alkyl, a compound of formula IV
Figure imgf000005_0004
and an inert organic solvent;
b) reacting the resulting compound of formula V
Figure imgf000006_0001
wherein R-ι, R2 and R3 have the meanings as described under formula I with O-methyl- hydroxylamine of formula VI
H2N-0-CH3 (VI),
to the compound of formul
Figure imgf000006_0002
wherein R-i, R2 and R3 have the meanings as described under formula I;
c) reducing the compound of formula VII to the compound of formula VIII
Figure imgf000006_0003
wherein R-i, R2 and R3 have the meanings as described under formula I
d) and reacting the compound of formula VIII with a compound of formula IX
Figure imgf000006_0004
in which R* is halogen, hydroxy or Ci-6 alkoxy, to the compound of formula I. a) WO 00/34229 describes a process for the preparation of a ketone of formula V by diazotizing an aniline of formula II and reacting the resulting diazonium salt with isopropenylacetate of formula IV. A disadvantage of this process is the accumulation of the very reactive diazonium salt in the reaction mixture. Diazonium salts in general are sensitive to physical agents such as heat, light, shock, static electricity and dehydration that can lead to rapid, uncontrollable decompositions and explosions. A further disadvantage is that 2 different equipments are needed to perform the reactions.
The process according to the invention uses easily accessible starting material, without the need of isolation or accumulation of diazonium salt and is therefore especially suitable for the large-scale preparation of a compound of formula I.
The compound of formula V can be prepared preferably by a one pot reaction adding the aniline of formula II to a mixture of isoprenylacetate of formula IV, an organic nitrite of formula III and a solvent. In preferred compounds of formula III, R4 is C4-C7alkyl. A preferred nitrite is tert-butyl nitriteand tert.-amyl nitrite.
The mixture of isoprenylacetate of formula IV, an organic nitrite of formula III and a solvent can additionally contain a copper compound which can be advantageous to increase yield and/or quality of the product. Preferred copper compounds are CuO, CuCI2 or CuS04. The amount of the copper compounds is preferably is 1 -20 mol% in the relation to the aniline of formula II. Advantageous for the reaction is a temperature of -10°C to 50°C. No isolation or accumulation of diazonium salt is required for this process step. Advantageously the same solvent is used for the aniline of formula II and the mixture of isoprenylacetate of formula IV and the organic nitrite of formula III. Suitable inert organic solvents are for example ketones, for example acetone, methylethylketone (MEK) or nitriles, for example acetonitrile. Preferred solvents are acetone and acetonitrile. The reaction without the use of copper can be environmentally more advantageous since copper waste can be avoided. Therefore, this process variant represents one of the preferred embodiments of this invention.
The compounds of formula II and III are either known or can be prepared according to methods well known in the art. Some compounds of formula II are commercially available, e.g. the compound of formula II, wherein R-i , R2 and R3 is chloro. Isoprenylacetate of formula IV is also commercially available. b) The compound of formula VII can be prepared preferably by a one pot reaction adding a salt of O-methyl-hydroxylamine; preferably the hydrochloride salt as aqueous solution to the compound of formula V in an inert solvent such as methanol or ethanol. Advantageous for this reaction is a temperature of 10- 90°C; preferably 40-60°C. The compound of formula VII can be furthermore purified by extraction into a suitable solvent such as hexane,
methylcyclohexane or toluene. c) The compound of formula VIII can be obtained by reduction from the compound of formula VII by treatment with a borane reagent such as sodium cyano borohydride, complexes of borane e.g. complexes of borane with organic amines, such as complexes of borane with triethylamine, trimethylamine, pyridine or 5-ethyl-2-methylpyridine in a suitable solvent such as an organic acid like acetic acid, or such as an organic alcohol like methanol, ethanol or isopropanol and optionally in the presence of a strong acid, such as hydrogen chloride or sulphuric acid.
The compound of formula VIII can be also prepared by hydrogenation of a compound of formula VII in the presence of a catalyst containing a transition metal such at Pt in a suitable solvent and and in the presence of at least 1 mol equivalent of a strong acid such as hydrogen chloride or sulphuric acid in a solvent such as an organic alcohol like methanol or acetic acid. Suitable temperatures include -10 to 60°C, preferably -10 to 30°C, and a hydrogen pressure of 0-0.1 MPa; preferably 0.3 - 0.5 MPa in particular 0.1 - 3 MPa, preferably 0.2 - 1 MPa. d) The compound of formula I is prepared by reacting a compound of formula VII with a compound of formula (IX) with an excess of the compound of formula IX, advantageously in a ratio of 1 :1 to 1 :1 .2. R* is preferably chloro. The reaction is advantageously performed in an inert solvent in the presence of a base. Such suitable solvents are for example dichloromethane, xylene, toluene or ethylacetate, preferably xylene. Suitable bases are for example sodium carbonate, sodium hydroxyde, triethylamine or pyridine, especially preferred bases are sodium hydroxyde and triethylamine.
The process according to the invention is especially suitable for the production of compounds of formula I, wherein at least one of R-i , R2 and R3 is different from hydrogen. The process according to the invention is especially suitable for the preparation of compounds of formula I, wherein at least one of R-i, R2 and R3 is halogen.
Further compounds of formula I can be advantageously prepared, wherein R-i, R2 and R3 are halogen, especially Ri, R2 and R3 are chloro.
Compounds of formula V which can be advantageously prepared as intermediates for the process according to this invention are described in Table 1 . Table 1 : Preferred compounds of formula V
Figure imgf000009_0001
Figure imgf000009_0002
Preparatory examples:
Example P1 : Preparation of 1 -(2,4,6-trichloro-phenyl)-propan-2-one (compound
CAS1228284-86-3):
Figure imgf000010_0001
In a 1 .51 sulfonation flask equipped with mechanical stirring, cooling funnel, dropping funnel and thermometer under nitrogen at ambient temperature filled with acetone (240 ml), were added isopropenyl acetate (66 ml, 0.60 mol), tert-butyl nitrite (40 ml, 0.30 mol) and cupric sulfate pentahydrate (2.5 g, 0.001 mol) . The resulting light green-blue suspension is stirred for 15min at ambient temperature. A solution of 2,4,6-trichloroaniline (40 g, 0.20 mol), dissolved in acetone (320 ml) was added dropwise over a period of 2 hours. During the addition, bubbling observed, temperature rose to 30°C and the mixture turned green. 1 Hour after the addition, an amber solution was obtained. The mixture was stirred for 6 hours. Completion of the reaction was confirmed by GC-MS. The crude mixture was concentrated under reduce pressure to remove most of the acetone and the residue was dissolved in ethyl acetate (300 ml) and wash with 1 M hydrochloric acid (2x300 ml), water (2x300 ml) potassium carbonate solution (300 ml) followed by water (300 ml). Combined basic aqueous were re-extracted with of ethyl acetate (150 ml). Combined organics were dried over sodium sulfate, and the organics were concentrated under reduced pressure to give crude 1 -(2,4,6-trichloro-phenyl)-propan-2-one (53g) as a dark brown oil. The crude was dissolved again in ethyl acetate (200 ml) and washed with 1 M sodium hydroxide (300 ml) 1 M hydrochloric acid (100 ml) and water (200 ml). The organic layers were dried and evaporated to give crude 1 -(2,4,6-trichloro-phenyl)-propan-2-one 49 g dark brown oil which crystallized.
1H NMR (400MHz, CDCI3): δ 2.26 (s,3H,CH3 ), 4.05(s,2H,CH2), 7.34 (s,2H, Ar-H) Example P2: Preparation of 1 -(4-bromo-2,6-dichloro-phenyl)-propan-2-one:
Figure imgf000010_0002
In a 50ml three-neck flask equipped with mechanical stirring, cooling funnel, dropping funnel and thermometer under nitrogen at ambient temperature filled with acetonitrile (10 ml), were added cuprous oxide (1 .5 g, 0.018 mol), isopropenyl acetate (13.6 ml, 0.125 mol) and tert-butyl nitrite (1 .7 ml, 0.0125 mol). The resulting red suspension is stirred for 15min at ambient temperature. A solution of 4-bromo-2,6-dichloroaniline (2.0 g, 0.0083 mol), dissolved in acetonitrile (15 ml) was added dropwise over a period of 20 minutes. During the addition, bubbling was observed. The mixture was stirred at 40°C for 20 hours. The red crude mixture was passed through celite to remove solid particles and concentrated under reduce pressure to give a brown solid. The residue was dissolved in dichloromethane (120 ml) and washed with water (2 x 50 ml) and brine (40 ml). Organics were dried over sodium sulfate and concentrated under reduced pressure to give crude 1 -(4-bromo-2,6-dichloro- phenyl)-propan-2-one (2.3g) as a dark brown oil.
1H NMR (400MHz, CDCI3): δ 2.25 (s,3H,CH3 ), 4.06(s,2H,CH2), 7.50 (s,2H, Ar-H)
Example P3: Preparation of 1 -(2,4,6-trichlorophenyl)-propan-2-one
Figure imgf000011_0001
In a 50ml three-neck flask equipped with stirring, cooling funnel, dropping funnel and thermometer under nitrogen at ambient temperature filled with acetonitrile (20 ml), isopropenyl acetate (31 g, 0.31 mol) and tert-amyl nitrite (3.6g, 0.031 mol). The resulting suspension is stirred for 15min at ambient temperature. A solution of 2,4,6-trichloroaniline (4.0 g, 0.020 mol), dissolved in acetonitrile (20 ml) was added dropwise over a period of 25 minutes. During the exothermic addition, bubbling was observed. The mixture was stirred at 40°C for 1 hour. The volatiles were distilled off at 55°C and 1 1 mbar. The residue was taken up with dichloromethane (50ml) and washed with water (20ml). The aqueous phase was extracted with an additional portion of dichloromethane (30ml). The combined organic phases were then concentrated under reduced pressure to give a crude 1 -(4-bromo-2,6- dichloro-phenyl)-propan-2-one (6.7g, 34.8% GC; 48% yield) as a dark brown oil.
Example P4: Preparation of 1 -(2,4,6-trichlorophenyl)-propan-2-one O-methyl-oxime
(compound CAS 1228284-89-6):
Figure imgf000012_0001
To a stirred solution of crude 1 -(2,4,6-trichloro-phenyl)-propan-2-one prepared as described in example P1 , (12g, 0.050 mol) in methanol (100 ml) was added pyridine (6.8 ml, 0.084 mol), followed by O-methyl-hydroxylamine hydrochloride (6.70 g, 0.080 mol). The resulting mixture was stirred at ambient temperature for 18 hours. Methanol was removed under reduced pressure and the residue poured in 1 N hydrochloric acid (300 ml) which was extracted with ethyl acetate (3 x 100 ml). Organics were combined, washed with brine, dried over sodium sulfate, filtered and evaporated under reduced pressure to give crude 1 -(2,4,6- trichloro-phenyl)-propan-2-one O-methyl-oxime E/Z-mixture (12.3 g, 92%), which was taken up for the next reduction step.
Example P5: Preparation of 1 -(2,4,6-trichlorophenyl)-propan-2-one O-methyl-oxime
(compound CAS 1228284-89-6
Figure imgf000012_0002
1 -(2,4,6-trichloro-phenyl)-propan-2-one (273 g, 1 .1 18 mol) was suspended in methanol (544 g) at ambient temperature. The resulting suspension was then heated under stirring to a temperature of 50°C (most of the solid is dissolved). Then O-methyl-hydroxylamine hydrochloride as a 30% solution in water (358 g, 1 .286 mol) was fed within 30-60 min. maintaining the temperature between 50-52°C. During the course of O-methyl- hydroxylamine hydrochloride addition the reaction mass turned into a two-phase system (liquid-liquid). At the end of O-methyl-hydroxylamine hydrochloride feed the pH was adjusted to 4-5 by slow addition of NaOH 30% (264 g 1 .981 mol). The mixture was then stirred for 1 -2 hours at 50-52°C to allow the reaction to go to completion. Subsequently the pH was adjusted to 7-8 by adding NaOH 30% (8.5 g, 0.064 mol). The product separated as a lower oily layer from the reaction mass in approx. 95% yield as a 2:1 mixture of E/Z-isomers.
Optionally the product can be extracted with a suitable solvent (e.g. hexane, methylcyclohexane, toluene). Depending on the quality requirements the resulting organic phase can be washed with water to remove residual sodium chloride.
1H NMR (400MHz, DMSO-d6): δ 1.51 (s,3H, minor-isomer), 1.82 (s,3H, major-isomer), 3.62 (s,3H, major-isomer), 3.74 (s,2H, major-isomer), 3.80 (s,3H, minor-isomer), 3.89 (s,2H, minor-isomer), 7.64 (s,2H, major-isomer), 7.70 (s,2H, minor-isomer). Example P6: Preparation of 0-methyl-N-[1 -methyl-2-(2,4,6-trichlorophenyl)-ethyll- hvdroxylamine (compound CAS 1228284-78-3):
Figure imgf000013_0001
a) Sodium cyanoborohydride:
To a stirred solution of crude 1 -(2,4,6-trichloro-phenyl)-propan-2-one O-methyl-oxime prepared as described in example P4, (12.3 g, 0.046 mol) in acetic acid (120 ml), sodium cyanoborohydride (6.1 g , 0.097 mol) was added portionwise at 12 to 15°C. The reaction mass was stirred at ambient temperature for 18 hours. TLC confirmed the completion of reaction, then solvent was evaporated under reduced pressure (co-evaporation with toluene twice). The resulting residue was poured on to 1 N sodium hydroxide solution (150 ml) and extracted with dichloromethane (2x100 ml). The combined organic layer was washed with water (2x 100 ml) followed by drying over anhydrous sodium sulfate before evaporating the solvent to afford crude 0-Methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-hydroxylamine (12.3 g, 100%).
1H NMR (400MHz, CDCI3): δ 0.91 -0.93 (d,3H), 2.72-2.77 (dd,1 H), 2.98-3.03(dd,1 H), 3.25- 3.30 (m,1 H), 3.93 (s,3H), 7.15(s,2H). b) Triethylaminoborane. To 1 -(2,4,6-trichloro-phenyl)-propan-2-one O-methyl-oxime prepared as described in example P4 (53.9g; assay 99%; 0.20mol) in methanol (100g) was added hydrogen chloride gas (22. Og; 0.60mol), whereas internal temperature in maintained at 20-30°C by external cooling. A colourless suspension was obtained. The reaction mixture was cooled to 15°C and triethylamino borane (borane triethylamine complex; 27.6g; assay 96%; 0.23mol) was dosed in during 60min maintaining internal temperature at 15°C. The reaction mass was stirred for another 2 hours allowing the mixture to warm to ambient temperature. Thereafter almost no starting material can be detected by HPLC. The reaction mixture was then added to preheated (85°C) water (126g) during 30min. A steady stream of gas was evolved; at the same time solvent was distilled. Heating was continued and the temperature maintained at 85-90°C for another 1 hour. Finally gas was no longer produced. The resulting mixture was cooled to 20-25°C. Sodium hydroxide (30% aqueous solution; 56.5g; 0.42mol) was carefully added in order to bring pH to 7.2-7.7. The resulting mixture was extracted with tert-butyl methyl ether (125ml). Phases were allowed to separate. The (lower) aqueous phase was split of. The (upper) organic phase was washed with water (2 x 100g) and evaporated. Crude 0-Methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-hydroxylamine (53.9g; assay 97.8%; yield 98.0%) was obtained as clear oil. c) Pt/H2
To 1 -(2,4,6-trichloro-phenyl)-propan-2-one O-methyl-oxime prepared as described in example P3 (54.2g; assay 98.4%; 0.20mol) in acetic acid (1 15g; 1.92mol) was added sulphuric acid (22.5g; assay 96%; 0.22mol) at such a rate that the mixture could be kept at 20-23°C. Platinum on charcoal (5.9g; Evonik F101 N/W 5%, water wet; assay 2.32% Pt) was added. The resulting mixture was transferred to an autoclave, which then was sealed and pressurized with hydrogen (0.8 MPa). The agitator of the autoclave was started and hydrogen pressure is maintained at 0.8 MPa. When no more hydrogen is consumed (usually after 5 hours), hydrogenation was interrupted by stopping agitation. Pressure was released and the atmosphere in the autoclave changed to nitrogen. The hydrogenation mixture was filtered in order to remove the heterogenous catalyst. To the filtrate was added water (220g) and a pH-probe was mounted. Aqueous sodium hydroxide (304g; assay 30%; 2.28mol) was fed until pH is above 9. The resulting mixture was extracted with tert-butyl methyl ether (300ml). Phases were allowed to separate. The (lower) aqueous phase was separated and discarded. The organic phase was washed with water (2 x 250g) and evaporated to dryness. Crude 0-Methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]- hydroxylamine (53. Og; assay 93.7%; yield 92.4%) was obtained as clear oil.
Example P7: Preparation of 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-ri-methyl-2-(2.4.6-trichlorophenyl)-ethyll-amide (compound CAS 1228284-64-7):
Figure imgf000015_0001
Variant a):
To a solution of 0-methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-hydroxylamine (12.3 g, 0.046 mol) prepared as described in example P5a, in dichloromethane (120 ml) was added triethylamine (7.7 ml, 0.055 mol) followed by dropwise addition of a solution of 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carbonyl chloride (9.1 g, 0.046 mol) in
dichloromethane (10 ml) at 0°C. After complete addition of acid chloride the mixture was stirred 5 hours at ambient temperature. When the TLC confirmed completion of the reaction, the reaction mass was washed with 1 N HCI (100 ml), followed by 1 N NaOH (100 ml), then with water (2x 100 ml) and finally with brine solution (50 ml) before drying over sodium sulfate and evaporation of the solvent. The resulting crude mass 20.5 g of a sticky dark brown oil was purified by column chromatography using 60-120 μ mesh silica gel and product collected at 40% ethyl acetate in hexane as eluent to give 3-difluoromethyl-1 - methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]- amide (7.9 g, 41 %) as off white solid, m.p: 1 10-1 12°C
1H NMR (400MHz, CDCI3): δ 1 .38-1 .39(d,3H), 3.20-3.26(dd,1 H), 3.32-3.37(dd,1 H), 3.70(s,3H), 3.97(s,3H), 4.88-4.93(m,1 H), 7.02-7.29(t,1 H), 7.27(s,2H), 7.81 (s,1 H)
MS [M+H]+ 426/428/430
Variant b):
To a solution of 0-methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-hydroxylamine (12.3 g, 0.046 mol) prepared as described in example P5a in Xylene (90 g) was added triethylamine (5.6 g, 0.055 mol) followed by addition of 3-difluoromethyl-1 -methyl-1 H- pyrazole-4-carbonyl chloride (40.1 g, 0.046 mol) at 70°C during 2 hours. After complete addition of acid chloride the mixture was stirred 2 hours at 70°C. The solution was washed twice with water and the volatiles were removed from the organic layer under reduced pressure. The resulting crude mass 23.6 g (sticky dark brown oil) was purified by crystallization from a mixture of 16 g xylene and 36 g methylcyclohexene to give 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-(2,4,6-trichloro- phenyl)-ethyl]-amide (17.0 g, 91.5%) as off white solid, m.p: 1 15-1 16°C.
Variant c):
To a solution of 0-methyl-N-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-hydroxylamine (3.92 g, 0.014 mol) prepared as described in example P5a in xylene (30g) was added an aqueous sodium hydroxide solution (30%, 2.3 g, 0.017 mol) in parallel to the addition of 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carbonyl chloride (3.2 g, 0.046 mol) dissolved in xylene (10g) at 56°C during 2 hours. After complete addition of acid chloride the mixture was stirred 2 hours at 56°C. The solution was washed twice with water (10 and 5 g) and the volatiles were removed from the organic layer under reduced pressure. The resulting crude mass 7.4g (sticky dark brown oil) was purified by crystallization from a mixture of xylene (7g )and methylcyclohexene (14g) to give 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1 -methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-amide (5.3 g, 87.8%) as off white solid, m.p: 1 15-1 16°C.

Claims

What is claimed is:
1 . A process for the preparation of the compound of formula I
Figure imgf000017_0001
wherein
Ri is hydrogen, halogen or d-C6alkyl;
R2 is hydrogen, halogen, CrC6alkyl, C2-C6alkenyl, C3-C6alkinyl, C3-C6cycloalkyl-C3-C6alkinyl, halophenoxy, halophenyl-C3-C6alkinyl,
Figure imgf000017_0002
CrC6haloalkyl, CrC6haloalkoxy, C2-C6haloalkenyl or C2-C6haloalkenyloxy; and
R3 is hydrogen, halogen or CrC6alkyl;
which process comprises
a) adding a compound of formula
Figure imgf000017_0003
wherein R-i , R2 and R3 have the meanings as described under formula I, in the presence of an inert organic solvent to a mixture comprising an organic nitrite of formula III
R4-0-N=0 (III), wherein R4 is CrC8alkyl, a compound of formula IV
Figure imgf000017_0004
and an inert organic solvent;
b) reacting the resulting compound of formula V
Figure imgf000018_0001
wherein R-i , R2 and R3 have the meanings as described under formula I with O-methyl- hydroxylamine of formula VI
H2N-0-CH3 (VI),
to the compound of formula VII
Figure imgf000018_0002
wherein R-i , R2 and R3 have the meanings as described under formula I;
c) reducing the compound of formula VII to the compound of formula VIII
Figure imgf000018_0003
wherein R-i , R2 and R3 have the meanings as described under formula I
d) and reacting the compound of formula VIII with a compound of formula IX
Figure imgf000018_0004
in which R* is halogen, hydroxy or Ci-6 alkoxy to the compound of formula I.
2. A process according to claim 1 for the preparation of a compound of formula I, wherein at least one of R-i, R2 and R3 is different from hydrogen.
3. A process according to claim 1 for the preparation of a compound of formula I, wherein at least one of R-i, R2 and R3 is halogen.
4. A process according to claim 1 for the preparation of a compound of formula I, wherein Ri, R2 and R3 are chloro.
5. A process according to claim 1 for the preparation of a compound of formula I, wherein R is C4-C7alkyl.
PCT/EP2013/053773 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides WO2013127764A1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
PL13705816T PL2819997T3 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic acid n-methoxy- [1 -methyl- 2 - phenylethyl]amides
CA2863467A CA2863467C (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid n-methoxy- [1-methyl-2-phenylethyl] amides
JP2014559177A JP6078563B2 (en) 2012-02-28 2013-02-26 Process for preparing phenyl substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy- [1-methyl-2-phenylethyl] amide
CN201380011368.1A CN104144914B (en) 2012-02-28 2013-02-26 For the preparation of the method for 3-difluoromethyl-1-methyl isophthalic acid H-pyrazoles-4-carboxylic acid methoxy-[1-methyl-2-phenyl-ethyl group]-acid amides of phenyl-replacement
DK13705816.0T DK2819997T3 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl-substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy- [1-methyl-2-phenylethyl] amides
KR1020147024947A KR102031809B1 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid n-methoxy-[1-methyl-2-phenylethyl] amides
ES13705816.0T ES2558586T3 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl-substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy- [1-methyl-2-phenylethyl] amides
AU2013225123A AU2013225123B2 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1H - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides
MX2014009948A MX347564B (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides.
BR112014020556A BR112014020556B1 (en) 2012-02-28 2013-02-26 process for the preparation of phenyl-substituted 3-difluoromethyl-1-methyl-1h-pyrazol-4-carboxylic acid n-methoxy [1-methyl-2-phenylethyl] amides
EP13705816.0A EP2819997B1 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic acid n-methoxy- [1 -methyl- 2 - phenylethyl]amides
US14/374,547 US9051272B2 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy-[1-methyl-2 phenylethyl] amides
IL233937A IL233937A (en) 2012-02-28 2014-08-04 Process for the preparation of phenyl substituted 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic n-methoxy-[1-methyl-2-phenylethyl]amides
ZA2014/05823A ZA201405823B (en) 2012-02-28 2014-08-07 Process for the preparation of phenyl substituted 3-diflouromethyl -1-methyl-1h-pyrazole-4-carboxylic acid n-methoxy-[1-methyl-2-phenylethyl]amides
HRP20160001TT HRP20160001T1 (en) 2012-02-28 2015-12-31 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl]amides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12157354 2012-02-28
EP12157354.7 2012-02-28

Publications (1)

Publication Number Publication Date
WO2013127764A1 true WO2013127764A1 (en) 2013-09-06

Family

ID=47748653

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/053773 WO2013127764A1 (en) 2012-02-28 2013-02-26 Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic n-methoxy- [1 -methyl- 2 - phenylethyl] amides

Country Status (20)

Country Link
US (1) US9051272B2 (en)
EP (1) EP2819997B1 (en)
JP (1) JP6078563B2 (en)
KR (1) KR102031809B1 (en)
CN (1) CN104144914B (en)
AR (1) AR090172A1 (en)
AU (1) AU2013225123B2 (en)
BR (1) BR112014020556B1 (en)
CA (1) CA2863467C (en)
CO (1) CO7051031A2 (en)
DK (1) DK2819997T3 (en)
ES (1) ES2558586T3 (en)
HR (1) HRP20160001T1 (en)
HU (1) HUE026564T2 (en)
IL (1) IL233937A (en)
MX (1) MX347564B (en)
PL (1) PL2819997T3 (en)
TW (1) TWI491594B (en)
WO (1) WO2013127764A1 (en)
ZA (1) ZA201405823B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016174042A1 (en) 2015-04-27 2016-11-03 BASF Agro B.V. Pesticidal compositions
WO2017207368A1 (en) 2016-06-02 2017-12-07 BASF Agro B.V. Fungicidal compositions
US10130095B2 (en) 2014-02-19 2018-11-20 BASF Agro B.V. Fungicidal compositions of pyrazolecarboxylic acid alkoxyamides
WO2020094527A1 (en) 2018-11-06 2020-05-14 Syngenta Crop Protection Ag Hydrogenation process of oxime derivatives
WO2020128091A1 (en) 2018-12-21 2020-06-25 Syngenta Participations Ag Nematicidal compositions
WO2022157122A1 (en) 2021-01-22 2022-07-28 Syngenta Crop Protection Ag Method for the control or suppression of phytopathogenic bacteria
WO2024038053A1 (en) 2022-08-16 2024-02-22 Syngenta Crop Protection Ag New use of pydiflumetofen

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108610290B (en) * 2018-06-11 2020-04-24 武汉工程大学 Preparation method of fluxapyroxad
GB201818117D0 (en) * 2018-11-06 2018-12-19 Syngenta Participations Ag Enantioselective process
CN115703701A (en) * 2021-08-16 2023-02-17 上海晓明检测技术服务有限公司 Method for continuously synthesizing 1- (2,4,6-trichloro-phenyl) -propan-2-one by micro-channel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0810195A1 (en) * 1996-05-29 1997-12-03 ALFA CHEMICALS ITALIANA S.p.A. Process for manufacturing 1-(3-trifluoromethyl)phenyl-propan-2-one intermediate in the synthesis of the fenfluramine
WO2000034229A1 (en) 1998-12-10 2000-06-15 Bayer Aktiengesellschaft Process for the preparation of strobilurin intermediates
WO2010063700A2 (en) 2008-12-05 2010-06-10 Syngenta Participations Ag Novel microbiocides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006099077A1 (en) * 2005-03-10 2006-09-21 Merck & Co., Inc. Novel crystalline forms of antidiabetic compounds
EP2592931A4 (en) * 2010-07-13 2013-12-11 Syngenta Participations Ag Safener compositions and methods for reducing mycotoxins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0810195A1 (en) * 1996-05-29 1997-12-03 ALFA CHEMICALS ITALIANA S.p.A. Process for manufacturing 1-(3-trifluoromethyl)phenyl-propan-2-one intermediate in the synthesis of the fenfluramine
WO2000034229A1 (en) 1998-12-10 2000-06-15 Bayer Aktiengesellschaft Process for the preparation of strobilurin intermediates
WO2010063700A2 (en) 2008-12-05 2010-06-10 Syngenta Participations Ag Novel microbiocides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI LIA ET AL: "Facile Synthesis of 1-Aryl-2-propanones from Aromatic Amine", SYNTHETIC COMMUNICATIONS: AN INTERNATIONAL JOURNAL FOR RAPID COMMUNICATION OF SYNTHETIC ORGANIC CHEMISTRY, TAYLOR & FRANCIS INC, PHILADELPHIA, PA; US, vol. 37, no. 6, 31 December 2007 (2007-12-31), pages 985 - 991, XP002666726, ISSN: 0039-7911, [retrieved on 20070224], DOI: 10.1080/00397910601163950 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130095B2 (en) 2014-02-19 2018-11-20 BASF Agro B.V. Fungicidal compositions of pyrazolecarboxylic acid alkoxyamides
WO2016174042A1 (en) 2015-04-27 2016-11-03 BASF Agro B.V. Pesticidal compositions
WO2017207368A1 (en) 2016-06-02 2017-12-07 BASF Agro B.V. Fungicidal compositions
WO2020094527A1 (en) 2018-11-06 2020-05-14 Syngenta Crop Protection Ag Hydrogenation process of oxime derivatives
WO2020128091A1 (en) 2018-12-21 2020-06-25 Syngenta Participations Ag Nematicidal compositions
WO2022157122A1 (en) 2021-01-22 2022-07-28 Syngenta Crop Protection Ag Method for the control or suppression of phytopathogenic bacteria
WO2024038053A1 (en) 2022-08-16 2024-02-22 Syngenta Crop Protection Ag New use of pydiflumetofen

Also Published As

Publication number Publication date
HRP20160001T1 (en) 2016-02-12
JP2015508794A (en) 2015-03-23
PL2819997T3 (en) 2016-03-31
AU2013225123B2 (en) 2016-10-20
EP2819997A1 (en) 2015-01-07
MX347564B (en) 2017-05-03
IL233937A (en) 2016-04-21
HUE026564T2 (en) 2016-06-28
KR20140138154A (en) 2014-12-03
CN104144914A (en) 2014-11-12
ES2558586T3 (en) 2016-02-05
TW201348209A (en) 2013-12-01
CA2863467C (en) 2020-03-10
BR112014020556B1 (en) 2019-11-26
CO7051031A2 (en) 2014-09-10
AU2013225123A1 (en) 2014-09-18
US9051272B2 (en) 2015-06-09
ZA201405823B (en) 2015-11-25
DK2819997T3 (en) 2016-01-18
TWI491594B (en) 2015-07-11
EP2819997B1 (en) 2015-10-28
IL233937A0 (en) 2014-09-30
US20150018562A1 (en) 2015-01-15
CN104144914B (en) 2016-03-02
CA2863467A1 (en) 2013-09-06
AR090172A1 (en) 2014-10-22
MX2014009948A (en) 2014-11-12
JP6078563B2 (en) 2017-02-08
KR102031809B1 (en) 2019-10-14

Similar Documents

Publication Publication Date Title
EP2819997B1 (en) Process for the preparation of phenyl substituted 3 - difluoromethyl - 1 -methyl - 1h - pyrazole - 4 - carboxylic acid n-methoxy- [1 -methyl- 2 - phenylethyl]amides
EP2230234B1 (en) Process for the preparation of rufinamide
EP1773783B1 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
CN110028489B (en) Method for preparing benzamide compound by pressure reduction method
EP2628730B1 (en) Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
CZ814488A3 (en) Process for preparing derivatives of cyclosporin
KR101902373B1 (en) Process for the preparation of substituted phenylpropanones
KR20160120009A (en) Novel process for preparing 4,4-difluoro-((2-dialkylamino) methylene)-3-oxobutanic acid alkyl ester
JP2011515335A (en) Process for preparing substituted biphenylanilides
EP2080756A2 (en) Method for making losartan
JP2896949B2 (en) Method for producing 1- (4-acylphenyl) azoles
JPS62255483A (en) Manufacture of 1-aryl-5-amino-pyrazole
EP1408025B1 (en) 3,3-dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino -4-nitrosopyrazoles or salts thereof by the use of the same
JPH06228103A (en) New octahydroacridine derivative and its production
JP3873796B2 (en) 3-hydrazono-2-hydroxyiminopropionitrile derivative and process for producing the same
JP2003155275A (en) Method for producing 5-amino-4-nitrosopyrazole derivative or its salt
WO2009109222A1 (en) Process for the preparation of rimonabant
JP2011500804A (en) Method for producing glucocorticoid receptor ligand

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13705816

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14374547

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2863467

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 233937

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: MX/A/2014/009948

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 14187079

Country of ref document: CO

ENP Entry into the national phase

Ref document number: 2014559177

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20147024947

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013705816

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013225123

Country of ref document: AU

Date of ref document: 20130226

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112014020556

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112014020556

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20140821